Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:March 24, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:March 24, 2023Withdrawn
Condition(s):Cardiac AffectionsLast Updated:October 18, 2018Completed
Condition(s):HIV InfectionsLast Updated:February 13, 2024Completed
Condition(s):SchizophreniaLast Updated:September 6, 2019Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:January 9, 2020Completed
Condition(s):Metastatic Breast CancerLast Updated:June 6, 2018Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Schizophreniform DisorderLast Updated:January 30, 2015Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Schizophreniform DisorderLast Updated:November 28, 2023Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Schizophreniform DisorderLast Updated:April 23, 2007Completed
Condition(s):Breast CancerLast Updated:February 17, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.